The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Open accessAbstract
Background—: Cardiac transthyretin (ATTR) amyloidosis is a progressive and fatal cardiomyopathy for which several promising therapies are in development. The diagnosis is frequently delayed or missed because of the limited specificity of echocardiography and the traditional requirement for histological confirmation. It has long been recognized that technetium-labeled bone scintigraphy tracers can localize to myocardial amyloid deposits, and use of this imaging modality for the diagnosis of cardiac ATTR amyloidosis has lately been revisited. We conducted a multicenter study to ascertain the diagnostic value of bone scintigraphy in this disease. Methods and Results—: Results of bone scintigraphy and biochemical investigations were analyzed from 1217 patients with suspected cardiac amyloidosis referred for evaluation in specialist centers. Of 857 patients with histologically proven amyloid (374 with endomyocardial biopsies) and 360 patients subsequently confirmed to have nonamyloid cardiomyopathies, myocardial radiotracer uptake on bone scintigraphy was >99% sensitive and 86% specific for cardiac ATTR amyloid, with false positives almost exclusively from uptake in patients with cardiac AL amyloidosis. Importantly, the combined findings of grade 2 or 3 myocardial radiotracer uptake on bone scintigraphy and the absence of a monoclonal protein in serum or urine had a specificity and positive predictive value for cardiac ATTR amyloidosis of 100% (positive predictive value confidence interval, 98.0–100). Conclusions—: Bone scintigraphy enables the diagnosis of cardiac ATTR amyloidosis to be made reliably without the need for histology in patients who do not have a monoclonal gammopathy. We propose noninvasive diagnostic criteria for cardiac ATTR amyloidosis that are applicable to the majority of patients with this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
Kyle, R. A., & Ma, G. (1995) · PubMed · Cited by 1,255
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Maceira, A. M., Joshi, J., Prasad, S. K., Moon, J. C., Perugini, E., Harding, I., Sheppard, M. N., Poole-Wilson, P. A., Hawkins, P. N., & Pennell, D. J. (2005) · Circulation · doi:10.1161/01.cir.0000152819.97857.9d · Cited by 982
Self-citationPerugini, E., Guidalotti, P. L., Salvi, F., Cooke, R. M. T., Pettinato, C., Riva, L., Leone, O., Farsad, M., Ciliberti, P., Bacchi-Reggiani, L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.073 · Cited by 981
Self-citationSafety and efficacy of RNAi therapy for transthyretin amyloidosis
Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208760 · Cited by 971
Self-citationVrana, J. A., Gamez, J. D., Madden, B. J., Theis, J. D., Bergen, H. R., & Dogan, A. (2009) · Blood · doi:10.1182/blood-2009-07-230722 · Cited by 904
Diagnosis and Management of the Cardiac Amyloidoses
Falk, R. H. (2005) · Circulation · doi:10.1161/circulationaha.104.489187 · Cited by 791
Self-citationTransthyretin (TTR) Cardiac Amyloidosis
Ruberg, F. L., & Berk, J. L. (2012) · Circulation · doi:10.1161/circulationaha.111.078915 · Cited by 708
Self-citationHighly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine
Bradwell, A. R., Carr-Smith, H. D., Mead, G. P., Tang, L. X., Showell, P. J., Drayson, M. T., & Drew, R. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.673 · Cited by 650
Fontana, M., Pica, S., Reant, P., Abdel-Gadir, A., Treibel, T. A., Banypersad, S. M., Maestrini, V., Barcella, W., Rosmini, S., Bulluck, H., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016567 · Cited by 626
Self-citationBokhari, S., Castaño, A., Pozniakoff, T., Deslisle, S., Latif, F., & Maurer, M. S. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.000132 · Cited by 622
Self-citationTanskanen, M., Peuralinna, T., Polvikoski, T., Notkola, I., Sulkava, R., Hardy, J., Singleton, A., Kiuru‐Enari, S., Paetau, A., Tienari, P. J., et al. (2008) · Annals of Medicine · doi:10.1080/07853890701842988 · Cited by 591
Pepys, M. B. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131243 · Cited by 559
Native T1 Mapping in Transthyretin Amyloidosis
Fontana, M., Banypersad, S. M., Treibel, T. A., Maestrini, V., Sado, D. M., White, S. K., Pica, S., Castelletti, S., Piechnik, S. K., Robson, M. D., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.10.008 · Cited by 432
Self-citationDrayson, M., Tang, L. X., Drew, R., Mead, G. P., Carr-Smith, H., & Bradwell, A. R. (2001) · Blood · doi:10.1182/blood.v97.9.2900 · Cited by 419
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
Pinney, J. H., Whelan, C. J., Petrie, A., Dungu, J., Banypersad, S. M., Sattianayagam, P., Wechalekar, A., Gibbs, S. D. J., Venner, C. P., Wassef, N., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000098 · Cited by 372
Self-citationCMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis
Dungu, J. N., Valencia, O., Pinney, J. H., Gibbs, S. D. J., Rowczenio, D., Gilbertson, J. A., Lachmann, H. J., Wechalekar, A., Gillmore, J. D., Whelan, C. J., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.08.015 · Cited by 344
Self-citationOnline Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations
Rowczenio, D. M., Noor, I., Gillmore, J. D., Lachmann, H. J., Whelan, C., Hawkins, P. N., Obici, L., Westermark, P., Grateau, G., & Wechalekar, A. D. (2014) · Human Mutation · doi:10.1002/humu.22619 · Cited by 308
Self-citationHutt, D. F., Quigley, A.-M., Page, J., Hall, M. L., Burniston, M., Gopaul, D., Lane, T., Whelan, C. J., Lachmann, H. J., Gillmore, J. D., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu107 · Cited by 250
Self-citationRapezzi, C., Quarta, C. C., Guidalotti, P. L., Longhi, S., Pettinato, C., Leone, O., Ferlini, A., Salvi, F., Gallo, P., Gagliardi, C., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1642-7 · Cited by 207
Self-citationYield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis
Fine, N. M., Arruda-Olson, A. M., Dispenzieri, A. A., Zeldenrust, S. R., Gertz, M. A., Kyle, R. A., Swiecicki, P. L., Scott, C. G., & Grogan, M. A. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.02.030 · Cited by 148
Self-citationGlaudemans, A. W. J. M., van Rheenen, R. W. J., van den Berg, M. P., Noordzij, W., Koole, M. J. B., Blokzijl, H., Dierckx, R., Slart, R. H. J. A., & Hazenberg, B. P. C. (2014) · Amyloid · doi:10.3109/13506129.2013.871250 · Cited by 148
Self-citationPathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Sekijima, Y., Kelly, J. W., & Ikeda, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404155 · Cited by 139
Benson, M. (2003) · Baillière's Best Practice & Research : Clinical Rheumatology · doi:10.1016/j.berh.2003.09.001 · Cited by 120
Booth, D. R., Gallimore, J. R., Hutchinson, W. L., Hohenester, E., Thompson, D. R., Wood, S., & Pepys, M. B. (1998) · Figshare · Cited by 84
Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology
Maurer, M. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.05.039 · Cited by 66
Self-citationDefining the Diagnosis in Echocardiographically Suspected Senile Systemic Amyloidosis
Quarta, C. C., Guidalotti, P., Longhi, S., Pettinato, C., Leone, O., Ferlini, A., Biagini, E., Grigioni, F., Reggiani, M. L. B., Lorenzini, M., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.02.015 · Cited by 44
Self-citationCastaño, A., Bokhari, S., & Maurer, M. S. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv328 · Cited by 43
Self-citationThe transthyretin amyloidoses: advances in therapy
Dubrey, S. W., Ackermann, E. J., & Gillmore, J. D. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-133224 · Cited by 42
Self-citation
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Self-citation2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Self-citation
Metadata
- Authors
- Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., Lachmann, H. J., Bokhari, S., Castano, A., Dorbala, S., Johnson, G. B., Glaudemans, A. W. J. M., Rezk, T., Fontana, M., Palladini, G., Milani, P., Guidalotti, P. L., Flatman, K., Lane, T., Vonberg, F. W., Whelan, C. J., Moon, J. C., Ruberg, F. L., Miller, E. J., Hutt, D. F., Hazenberg, B. P., Rapezzi, C., & Hawkins, P. N.
- Venue
- Circulation
- Published
- 2016-06-14
- Volume
- 133
- Issue
- 24
- Pages
- 2404-2412
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2337532627
- Cited by
- 2,081
- References
- 28
- FWCI
- 57.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.